Psychiatry and Neurology, Neurology · Twin Falls, ID
NPI
1871683409
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1840 Canyon Crest Dr
Twin Falls, ID, 83301
Phone (801) 585-6387
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
816 services
Medicare patients, 2024
316
Average age 72
Drug cost, 2024
$2.0M
6,260 prescriptions
Company payments, 2025
$1,573
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John D Steffens was code 99213 (office e&m - established), 255 times for 184 patients. In total John D Steffens billed 816 services in 24 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 255 | 184 | $40.18 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 253 | 179 | $11.62 | $2,940 |
| 99214 Office E&M - Established | Office | 159 | 113 | $62.77 | $9,980 |
| 99212 Office E&M - Established | Office | 23 | 20 | $19.43 | $447 |
| 99215 Office E&M - Established | Office | 23 | 19 | $94.70 | $2,178 |
| 95970 Electrical Nerve Conductivity | Office | 17 | 13 | $11.25 | $191 |
By year: 2022 $33K for 684 services; 2023 $30K for 625 services; 2024 $30K for 816 services.
Medicare prescription drug claims, 2024
In 2024, the drug John D Steffens prescribed most often to Medicare patients was Carbidopa-Levodopa Er (Carbidopa/Levodopa), with 467 prescriptions and refills. In total John D Steffens wrote 6,260 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 467 | 986 | 111 | $58K |
| Donepezil Hcl Generic | 298 | 754 | 86 | $3,478 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 260 | 636 | 69 | $15K |
| Zonisamide Generic | 239 | 521 | 50 | $7,000 |
| Quetiapine Fumarate Generic | 217 | 416 | 55 | $2,950 |
| Gabapentin Generic | 200 | 416 | 55 | $4,534 |
| Clonazepam Generic | 184 | 257 | 37 | $1,148 |
| Amantadine Amantadine Hcl | 167 | 433 | 51 | $13K |
| Topiramate Generic | 167 | 296 | 33 | $2,838 |
| Baclofen Generic | 166 | 312 | 40 | $5,577 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 162 | 388 | 39 | $4,895 |
| Duloxetine Hcl Generic | 150 | 314 | 36 | $4,343 |
| Lamotrigine Generic | 121 | 259 | 25 | $2,399 |
| Memantine Hcl Generic | 100 | 242 | 26 | $3,341 |
| Primidone Generic | 94 | 216 | 22 | $2,186 |
Brand drugs: 476 claims; generic drugs: 5,784 claims; opioid claims: 163.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John D Steffens $1,573 ($1,573 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $515.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $515 |
| EMD Serono, Inc. MRK.DE | 19 | $244 |
| ACADIA Pharmaceuticals Inc ACAD | 17 | $163 |
| Celgene Corporation BMY | 4 | $103 |
| Argenx US, Inc. ARGX | 5 | $98.12 |
| UCB, Inc. UCB.BR | 3 | $79.9 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $71.26 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $63.79 |
| TG Therapeutics, Inc. TGTX | 3 | $53.01 |
| Biogen, Inc. BIIB | 2 | $48.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.